IP Library Granted Patent US 12,468,175
Granted Patent B2
US 12,468,175 · App. 18/425,813 · Granted Nov 11, 2025

Ophthalmic lenses with light scattering for treating myopia

Inventors: Peter Hones (Menlo Park, CA); Thomas W. Chalberg, Jr. (Menlo Park, CA)
Assignee: SightGlass Vision, Inc.
G02C7/021G02C7/027G02C7/061G02C7/10G02C7/165A61B3/1173G02C2202/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,468,175
App. No.
18/425,813
Granted
Nov 11, 2025
Kind
B2
Abstract

An ophthalmic lens that includes a lens material having two opposing curved surfaces, the curved surfaces defining a lens axis; and a light scattering region surrounding a clear aperture. The clear aperture and the light scattering region are substantially centered on the lens axis, and the light scattering region has a plurality of spaced apart scattering centers (e.g., on a lens surface and/or embedded in the lens material) sized and shaped to scatter incident light, the scattering centers being arranged in a pattern that includes a random variation in spacing between adjacent dots and/or a random variation in dot size.

Claims (32)

1 . An ophthalmic lens, comprising:

a lens material having a curved surface; and

a plurality of scattering centers sized and shaped to scatter incident light, the scattering centers being arranged in an area of the surface a pattern such that each scattering center is located at or near a corresponding array site of a two-dimensional array in which the spacing between array sites is a first distance, D x , in one direction in a plane of the array and a second distance, D y , in a second direction in the plane of the array, the second direction being orthogonal to the first direction,

wherein a center of each scattering center is displaced from a corresponding array site by an amount δx in the first direction and by an amount δy in the second direction, where

δ x=A x ·D x ·RN[ 0,1], and

δ y=A y ·D y ·RN[ 0,1],

wherein A x and A y are amplitudes that are between 0 and 1 and RN is a random number between 0 and 1.

2 . The ophthalmic lens of claim 1 , wherein the plurality of scattering centers are arranged in a scattering region, and

wherein the plurality of scattering centers are sized and arranged to reduce an image contrast of an object viewed through the scattering region by at least 30% compared to an image contrast of the object viewed through a clear aperture of the ophthalmic lens.

3 . The ophthalmic lens of claim 1 , wherein each scattering center comprises a depression on the surface.

4 . The ophthalmic lens of claim 1 , wherein spacing between array sites is in a range from 0.2 mm to 1 mm.

5 . The ophthalmic lens of claim 4 , wherein the scattering centers have a maximum dimension in a plane of the array in a range from 0.08 mm to 0.5 mm.

6 . The ophthalmic lens of claim 1 , wherein at least some of the scattering centers have a dimension in the plane of the array that varies from the dimension of other of the scattering centers.

7 . The ophthalmic lens of claim 1 , wherein a variation of the dimension of the at least some scattering centers in the plane of the array is 0.5 times or less than a nominal value.

8 . The ophthalmic lens of claim 1 , further comprising a lens axis and a clear aperture on the surface free of the scattering centers, the lens axis intersecting the clear aperture.

9 . The ophthalmic lens of claim 1 , wherein the pattern includes irregular variations in scattering center size.

10 . The ophthalmic lens of claim 1 , wherein the scattering centers are substantially circular in shape in the plane of the array.

11 . The ophthalmic lens of claim 1 , wherein the scattering centers are sized and shaped to scatter incident light into a range of forward scattering angles between 3 degrees and 30 degrees.

12 . The ophthalmic lens of claim 1 , wherein the scattering centers are sized and shaped so that the area has a haze in a range from 10% to 50%.

13 . The ophthalmic lens of claim 1 , wherein the ophthalmic lens is one of a plano lens, a single vision lens, and a multivision lens.

14 . The ophthalmic lens of claim 1 , wherein the ophthalmic lens is one of an eyeglass lens and a contact lens.

15 . The ophthalmic lens of claim 1 , wherein the area is an annular area.

16 . Eyeglasses, comprising:

eyeglass frames; and

the ophthalmic lens of claim 1 mounted in the eyeglass frames, the area containing the scattering centers corresponding to a wearer's peripheral visual field.

17 . The eyeglasses of claim 16 , wherein:

the plurality of scattering centers are arranged in a scattering region;

the one or more ophthalmic lenses have optical power to correct a vision of a wearer to 20/20 or better through a clear aperture of the ophthalmic lens; and

for at least a portion of the peripheral vision of the wearer through the scattering region, the lenses correct the vision of the wearer to 20/25 or better.

18 . A method of treating eye-length related disorders, comprising:

identifying, in a patient, an eye-length related disorder; and

reducing a contrast of images in a periphery of vision of the patient by using the eyeglasses of claim 16 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2024
From: HONES, PETER; CHALBERG, THOMAS W., JR
To: SIGHTGLASS VISION, INC.
Reel/Frame 066295/0676 →
Continuity (6)
Continuation 17141055 · Jan 4, 2021
Continuation 16236961 · Dec 31, 2018
Provisional Application 62671992 · May 15, 2018
Provisional Application 62663938 · Apr 27, 2018
Provisional Application 62624038 · Jan 30, 2018
Related Publication 20240192522A1 · Jun 13, 2024
References Cited (336)
US 149270A · Watson · 1874 [cited by applicant]
US 338003A · Ward · 1886 [cited by applicant]
US 506983A · Diemmer et al. · 1893 [cited by applicant]
US 712466A · Taylor · 1902 [cited by applicant]
US 1959915A · Guthrie · 1934 [cited by applicant]
US 3507566A · Knapp · 1970 [cited by applicant]
US 4194814A · Fischer et al. · 1980 [cited by applicant]
US 4338003A · Adrian · 1982 [cited by applicant]
US 4704016A · de Carle · 1987 [cited by applicant]
US 4710327A · Neefe · 1987 [cited by applicant]
US 4889421A · Cohen · 1989 [cited by applicant]
US 4909818A · Jones · 1990 [cited by applicant]
US 5034100A · Sides · 1991 [cited by applicant]
US 5044742A · Cohen · 1991 [cited by applicant]
US 5116112A · Rawlings · 1992 [cited by applicant]
US 5260727A · Oksman et al. · 1993 [cited by applicant]
US 5585968A · Guhman et al. · 1996 [cited by applicant]
US 5800992A · Fodor et al. · 1998 [cited by applicant]
US 5837461A · Neitz · 1998 [cited by applicant]
US 5867247A · Martin et al. · 1999 [cited by applicant]
US 5905561A · Lee et al. · 1999 [cited by applicant]
US 5926250A · Mukaiyama et al. · 1999 [cited by applicant]
US 6149270A · Hayashi · 2000 [cited by applicant]
US 6343861B1 · Kris et al. · 2002 [cited by applicant]
US 6582908B2 · Fodor et al. · 2003 [cited by applicant]
US 6706867B1 · Lorenz · 2004 [cited by applicant]
US 6712466B2 · Dreher · 2004 [cited by applicant]
US 6712467B1 · Kitani · 2004 [cited by applicant]
US 6754299B2 · Patch · 2004 [cited by applicant]
US 6836619B2 · Ohmura · 2004 [cited by applicant]
US 6997554B2 · Nakada et al. · 2006 [cited by applicant]
US 7025460B2 · Smith et al. · 2006 [cited by applicant]
US 7506983B2 · To et al. · 2009 [cited by applicant]
US 7604351B2 · Fukuma et al. · 2009 [cited by applicant]
US 7665842B2 · Ho et al. · 2010 [cited by applicant]
US 7766482B2 · Smith et al. · 2010 [cited by applicant]
US 7862171B2 · Varnas et al. · 2011 [cited by applicant]
US 7901075B2 · Rooney et al. · 2011 [cited by applicant]
US 7992997B2 · Varnas · 2011 [cited by applicant]
US 7997727B2 · Ho et al. · 2011 [cited by applicant]
US 8052278B2 · Bovet et al. · 2011 [cited by applicant]
US 8057034B2 · Ho et al. · 2011 [cited by applicant]
US 8079702B2 · Ballet et al. · 2011 [cited by applicant]
US 8115792B2 · Petsch et al. · 2012 [cited by applicant]
US 8162477B2 · Carimalo et al. · 2012 [cited by applicant]
US 8240847B2 · Holden et al. · 2012 [cited by applicant]
US RE43851E · To et al. · 2012 [cited by applicant]
US 8342684B2 · Ho et al. · 2013 [cited by applicant]
US 8500278B2 · Lo et al. · 2013 [cited by applicant]
US 8540365B2 · Varnas · 2013 [cited by applicant]
US 8684520B2 · Lindacher et al. · 2014 [cited by applicant]
US 8690319B2 · Menezes · 2014 [cited by applicant]
US 8807747B2 · Guilloux et al. · 2014 [cited by applicant]
US RE45147E · To et al. · 2014 [cited by applicant]
US 8833936B2 · Varnas · 2014 [cited by applicant]
US 8926092B2 · Weeber · 2015 [cited by applicant]
US 8931897B2 · Holden et al. · 2015 [cited by applicant]
US 8950860B2 · Tse et al. · 2015 [cited by applicant]
US 8951729B2 · Neitz et al. · 2015 [cited by applicant]
US 8992010B2 · Ho et al. · 2015 [cited by applicant]
US 8998408B2 · Wei et al. · 2015 [cited by applicant]
US 9360683B2 · Buehren · 2016 [cited by applicant]
US 9417463B2 · Brennan et al. · 2016 [cited by applicant]
US 9423633B2 · Ho et al. · 2016 [cited by applicant]
US 9547182B2 · Collins et al. · 2017 [cited by applicant]
US 9594259B2 · Brennan et al. · 2017 [cited by applicant]
US 9625739B2 · Brennan et al. · 2017 [cited by applicant]
US 9664927B2 · Wright et al. · 2017 [cited by applicant]
US 9709819B2 · Lippens et al. · 2017 [cited by applicant]
US 9720253B2 · Neitz et al. · 2017 [cited by applicant]
US 9733494B2 · Brennan et al. · 2017 [cited by applicant]
US 9746693B2 · Peloux et al. · 2017 [cited by applicant]
US 9829722B2 · Tse et al. · 2017 [cited by applicant]
US 10012849B2 · Collins et al. · 2018 [cited by applicant]
US RE47006E · To et al. · 2018 [cited by applicant]
US 10042091B2 · Kildishev et al. · 2018 [cited by applicant]
US 10061143B2 · Brennan et al. · 2018 [cited by applicant]
US 10156737B2 · Martinez et al. · 2018 [cited by applicant]
US 10203522B2 · Bakaraju et al. · 2019 [cited by applicant]
US 10231897B2 · Tse et al. · 2019 [cited by applicant]
US 10247964B2 · Sankaridurg et al. · 2019 [cited by applicant]
US 10302962B2 · Neitz et al. · 2019 [cited by applicant]
US 10429670B2 · Newman · 2019 [cited by applicant]
US 10571717B2 · Neitz et al. · 2020 [cited by applicant]
US 10787707B2 · Neitz et al. · 2020 [cited by applicant]
US 10795181B2 · Neitz et al. · 2020 [cited by applicant]
US 10884264B2 · Hones et al. · 2021 [cited by applicant]
US 11048102B2 · Neitz · 2021 [cited by applicant]
US 11543681B2 · Neitz et al. · 2023 [cited by applicant]
US 11899288B2 · Neitz et al. · 2024 [cited by applicant]
US 20020095211A1 · Young · 2002 [cited by applicant]
US 20020140900A1 · Streibig · 2002 [cited by applicant]
US 20030082576A1 · Jones et al. · 2003 [cited by applicant]
US 20040110179A1 · Shuber · 2004 [cited by applicant]
US 20040150787A1 · Niculas · 2004 [cited by applicant]
US 20050033422A1 · Zhao et al. · 2005 [cited by applicant]
US 20050208555A1 · Raimond · 2005 [cited by applicant]
US 20060055627A1 · Wilson · 2006 [cited by applicant]
US 20060082729A1 · To et al. · 2006 [cited by applicant]
US 20060118263A1 · Silvestrini · 2006 [cited by applicant]
US 20060235428A1 · Silvestrini · 2006 [cited by applicant]
US 20060285071A1 · Erickson et al. · 2006 [cited by applicant]
US 20070026167A1 · Bourdelais et al. · 2007 [cited by applicant]
US 20070115431A1 · Smith et al. · 2007 [cited by applicant]
US 20070247588A1 · Cano · 2007 [cited by applicant]
US 20070296916A1 · Holden et al. · 2007 [cited by applicant]
US 20080030675A1 · Dillon · 2008 [cited by applicant]
US 20080084534A1 · Lindacher et al. · 2008 [cited by applicant]
US 20080151183A1 · Altmann · 2008 [cited by applicant]
US 20080218687A1 · Philips · 2008 [cited by applicant]
US 20080221674A1 · Blum et al. · 2008 [cited by applicant]
US 20080309882A1 · Thorn et al. · 2008 [cited by applicant]
US 20090059168A1 · Miller et al. · 2009 [cited by applicant]
US 20090115962A1 · Bovet et al. · 2009 [cited by applicant]
US 20090257026A1 · Varnas et al. · 2009 [cited by applicant]
US 20100021889A1 · Juo · 2010 [cited by applicant]
US 20100091240A1 · Drobe et al. · 2010 [cited by applicant]
US 20100149488A1 · Lo et al. · 2010 [cited by applicant]
US 20110051079A1 · Martinez et al. · 2011 [cited by applicant]
US 20110194195A1 · Zalevsky et al. · 2011 [cited by applicant]
US 20110313058A1 · Neitz et al. · 2011 [cited by applicant]
US 20120014977A1 · Furihata · 2012 [cited by applicant]
US 20120062836A1 · Tse et al. · 2012 [cited by applicant]
US 20120182520A1 · Neitz et al. · 2012 [cited by applicant]
US 20130053425A1 · To et al. · 2013 [cited by applicant]
US 20130103147A1 · Christie et al. · 2013 [cited by applicant]
US 20130107206A1 · Slater · 2013 [cited by applicant]
US 20140036224A1 · Spaulding et al. · 2014 [cited by applicant]
US 20140080900A1 · Neitz et al. · 2014 [cited by applicant]
US 20140111763A1 · Griffin · 2014 [cited by applicant]
US 20150036102A1 · Ghosh et al. · 2015 [cited by applicant]
US 20150109574A1 · Tse et al. · 2015 [cited by applicant]
US 20150111782A1 · Neitz et al. · 2015 [cited by applicant]
US 20150160477A1 · Dai et al. · 2015 [cited by applicant]
US 20150316788A1 · Holden et al. · 2015 [cited by applicant]
US 20150331255A1 · Sankaridurg et al. · 2015 [cited by applicant]
US 20160026000A1 · Kester · 2016 [cited by applicant]
US 20160143801A1 · Lam et al. · 2016 [cited by applicant]
US 20160377884A1 · Lau et al. · 2016 [cited by applicant]
US 20170018916A1 · Itsuki et al. · 2017 [cited by applicant]
US 20170115509A1 · Brennan et al. · 2017 [cited by applicant]
US 20170131567A1 · To et al. · 2017 [cited by applicant]
US 20170168320A1 · Tsubota et al. · 2017 [cited by applicant]
US 20170184875A1 · Newman · 2017 [cited by applicant]
US 20170189168A1 · Zickler et al. · 2017 [cited by applicant]
US 20170192252A1 · Brennan et al. · 2017 [cited by applicant]
US 20170276963A1 · Brennan et al. · 2017 [cited by applicant]
US 20170292160A1 · Neitz et al. · 2017 [cited by applicant]
US 20170336653A1 · Bakaraju · 2017 [cited by applicant]
US 20180112268A1 · Neitz et al. · 2018 [cited by applicant]
US 20180275425A1 · Collins et al. · 2018 [cited by applicant]
US 20180275427A1 · Lau et al. · 2018 [cited by applicant]
US 20180284326A1 · Arima et al. · 2018 [cited by applicant]
US 20190033619A1 · Neitz et al. · 2019 [cited by applicant]
US 20190302477A1 · Neitz et al. · 2019 [cited by applicant]
US 20200073147A1 · Bakaraju et al. · 2020 [cited by applicant]
US 20200089023A1 · Zhou et al. · 2020 [cited by applicant]
US 20200271955A1 · Neitz et al. · 2020 [cited by applicant]
US 20200393699A1 · Neitz · 2020 [cited by applicant]
US 20210341753A1 · Neitz · 2021 [cited by applicant]
US 20220035179A1 · Rappon et al. · 2022 [cited by applicant]
US 20230107026A1 · Neitz et al. · 2023 [cited by applicant]
US 20230137646A1 · Neitz et al. · 2023 [cited by applicant]
US 20230384618A1 · Neitz et al. · 2023 [cited by applicant]
AU 2005289302 · 2006 [cited by applicant]
CA 2278249 · 1999 [cited by applicant]
CN 1909860 · 2007 [cited by applicant]
CN 2924572 · 2007 [cited by applicant]
CN 101017535A · 2007 [cited by applicant]
CN 101198434 · 2008 [cited by applicant]
CN 101273882 · 2008 [cited by applicant]
CN 101595420 · 2009 [cited by applicant]
CN 101730500 · 2010 [cited by applicant]
CN 101268408 · 2011 [cited by applicant]
CN 102238927 · 2011 [cited by applicant]
CN 103097940 · 2013 [cited by applicant]
CN 103576338 · 2014 [cited by applicant]
CN 103959138 · 2014 [cited by applicant]
CN 104094164 · 2014 [cited by applicant]
CN 104094165 · 2014 [cited by applicant]
CN 103293707 · 2014 [cited by applicant]
CN 104656271 · 2015 [cited by applicant]
CN 104678572 · 2015 [cited by applicant]
CN 105378545 · 2016 [cited by applicant]
CN 102892380 · 2016 [cited by applicant]
CN 103870058A · 2024 [cited by applicant]
EP 0457612 · 1991 [cited by applicant]
EP 1042700 · 2002 [cited by applicant]
EP 1799166 · 2007 [cited by applicant]
EP 2131721 · 2009 [cited by applicant]
EP 2616876 · 2013 [cited by applicant]
EP 2962155 · 2016 [cited by applicant]
EP 2548533 · 2018 [cited by applicant]
EP 3614981 · 2020 [cited by applicant]
EP 3667401 · 2020 [cited by applicant]
EP 3746001 · 2020 [cited by applicant]
EP 3931626 · 2022 [cited by applicant]
HK 1210838 · 2016 [cited by applicant]
JP S5829627 · 1983 [cited by applicant]
JP 2003004907 · 2003 [cited by applicant]
JP 2003029216 · 2003 [cited by applicant]
JP 2003075987A · 2003 [cited by applicant]
JP 2004514921 · 2004 [cited by applicant]
JP 2008040497 · 2008 [cited by applicant]
JP 2008512725 · 2008 [cited by applicant]
JP 2008514318 · 2008 [cited by applicant]
JP 2009511962 · 2009 [cited by applicant]
JP 4891249 · 2012 [cited by applicant]
JP 2012513252 · 2012 [cited by applicant]
JP 2012185348 · 2012 [cited by applicant]
JP 2013537317 · 2013 [cited by applicant]
JP 2015197679 · 2015 [cited by applicant]
JP 2016018158 · 2016 [cited by applicant]
JP 2017068216 · 2017 [cited by applicant]
JP 2017510851 · 2017 [cited by applicant]
JP 2019529968 · 2019 [cited by applicant]
KR 100686551 · 2007 [cited by applicant]
KR 100840845 · 2008 [cited by applicant]
TW 279510 · 1996 [cited by applicant]
TW I446830 · 2001 [cited by applicant]
TW 201211618 · 2012 [cited by applicant]
TW I370278 · 2012 [cited by applicant]
TW 201307942 · 2013 [cited by applicant]
TW I493240 · 2015 [cited by applicant]
TW I530727 · 2016 [cited by applicant]
TW I559044 · 2016 [cited by applicant]
TW I561885 · 2016 [cited by applicant]
TW 201737238A · 2017 [cited by applicant]
WO WO1986006846 · 1986 [cited by applicant]
WO WO1997031286 · 1997 [cited by applicant]
WO WO1999066366 · 1999 [cited by applicant]
WO WO2000052516 · 2000 [cited by applicant]
WO WO2002031585 · 2002 [cited by applicant]
WO WO2006034652 · 2006 [cited by applicant]
WO WO2006113149 · 2006 [cited by applicant]
WO WO2007082268 · 2007 [cited by applicant]
WO WO2007132834 · 2007 [cited by applicant]
WO WO2008026674 · 2008 [cited by applicant]
WO WO2008045847 · 2008 [cited by applicant]
WO WO2008059178 · 2008 [cited by applicant]
WO WO2008083418 · 2008 [cited by applicant]
WO WO2010019397 · 2010 [cited by applicant]
WO WO2010075319 · 2010 [cited by applicant]
WO WO2010088644 · 2010 [cited by applicant]
WO WO2011031948 · 2011 [cited by applicant]
WO WO2012034265 · 2012 [cited by applicant]
WO WO2012097213 · 2012 [cited by applicant]
WO WO2012138426A2 · 2012 [cited by applicant]
WO WO2013015743 · 2013 [cited by applicant]
WO WO2013082545 · 2013 [cited by applicant]
WO WO2013134825 · 2013 [cited by applicant]
WO WO2014194444 · 2014 [cited by applicant]
WO WO2015055322 · 2015 [cited by applicant]
WO WO2015147758 · 2015 [cited by applicant]
WO WO2015186723 · 2015 [cited by applicant]
WO WO2016117448A1 · 2016 [cited by applicant]
WO WO2016138512 · 2016 [cited by applicant]
WO WO2017178430 · 2017 [cited by applicant]
WO WO2018026697 · 2018 [cited by applicant]
WO WO2018076057 · 2018 [cited by applicant]
WO WO2018208724 · 2018 [cited by applicant]
WO WO2019166653 · 2019 [cited by applicant]
WO WO2020138127 · 2020 [cited by applicant]
Office Action in Chinese Appln. No. 201980016486.9, dated Dec. 2, 2024, 21 pages (with English translation). [cited by applicant]
Ahern “Biochemical, reagents kits offer scientists good return on investment,” The Scientist, Jul. 1995, 9(15):20. [cited by applicant]
Anstice et al., “Effect of dual-focus soft contact lens wear on axial myopia progression in children,” Ophthalmology, 2011, 1152-1161. [cited by applicant]
Applied Biosystems—Product Bulletin—Automated DNA Sequencing [online] “ABI Prism® BigDyeTM Primer Sequencing Kit,” 2000, retrieved from URL <tools.thermofisher.com/content/sfs/brochures/cms_040730.pdf>, 4 pages. [cited by applicant]
Brennan et al., “Commonly held beliefs about myopia that lack a robust evidence base,” Eye & Contact Lens, Jul. 2019, 45(4):215-225. [cited by applicant]
Carkeet et al., “Repeatability of IOLMaster Biometry in Children, Optometry and Vision Science”, Nov. 2004, 81(11) : 829-834. [cited by applicant]
Carroll et al., “Cone photoreceptor mosaic disruption associated with Cys203Arg mutation in the M-cone opsin,” Proceedings of the National Academy of Sciences of the United States of America, 2009, 106(49):20948-20953. [cited by applicant]
Carroll et al., “Estimates of L:M cone ratio from ERG flicker photometry and genetics”, Journal of Vision, 2002, 2(8):531-542. [cited by applicant]
Carroll et al., “Functional photoreceptor loss revealed with adaptive optics: An alternate cause of color blindness,” Proceedings of the National Academy of Sciences of the United States of America, 2004, 101(22):8461-8… [cited by applicant]
Carroll, J., McMahon, C., Neitz, M., & Neitz, J. (2000). Flicker-photometric electroretinogram estimates of L: M cone photoreceptor ratio in men with photopigment spectra derived from genetics. Journal of The Optical So… [cited by applicant]
Chamberlain et al., “A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control”, Optom Vis Sci, 2019, 96(8): 556-567. [cited by applicant]
Cheng et al., “Effect of Bifocal and Prismatic Bifocal Spectacles on Myopia Progression in Children: Three-Year Results of a Randomized Clinical Trial”, JAMA Ophthalmology, Mar. 2014, 132(3):258-264. [cited by applicant]
Cheng et al., “Soft contact lenses with positive spherical aberration for myopia control,” Optometry and Vision Science, Apr. 2016, 93(4):353-366. [cited by applicant]
Crognale et al., “Characterization of a novel form of X-linked incomplete achromatopsia”, Visual Neuroscience, 2004, 21(3):197-203. [cited by applicant]
Davidoff, “Cone opsin gene variants in color blindness and other vision disorders,” 2015, Retrieved from the Internet: <https://digital.lib.washington.edu/researchworks/bitstream/handle/1773/33578/Davidoff_washington_02… [cited by applicant]
Drummond-Borg, et al., “Molecular patterns of X chromosome-linked color vision genes among 134 men of European ancestry,” Proceedings of the National Academy of Sciences of the United States of America, Feb. 1989, 86:98… [cited by applicant]
EP Extended European Search Report in European Appln. No. 19747437.2, dated Mar. 16, 2021, 10 pages. [cited by applicant]
Gardner et al., “Three Different Cone Opsin Gene Array Mutational Mechanisms with Genotype-Phenotype Correlation and Functional Investigation of Cone Opsin Variants” Human Mutation (2014) vol. 35(11), pp. 1354-1362. [cited by applicant]
GeneCards [online], “GeneCard for the OPNIMW gene”, retrieved on Apr. 6, 2020, retrieved from <genecards.org/cgi-bin/carddisp_pl?gene=OPNIMW>, 27 pages. [cited by applicant]
Greenwald et al., “Role of a Dual Splicing and Amino Acid Code in Myopia, Cone Dysfunction and Cone Dystrophy Associated with L/M Opsin Interchange Mutations,” Translation Vision Science & Technology, vol. 6, No. 3, dat… [cited by applicant]
Gunther et al., “Individual differences in chromatic (red/green) contrast sensitivity are constrained by the relative number of L-versus M-cones in the eye,” Vision Research, May 2002, 42(11):1367-1378. [cited by applicant]
Gwiazda et al., “A Randomized Clinical Trial of Progressive Addition Lenses versus Single Vision Lenses on the Progression of Myopia in Children”, Investigative Ophthalmology & Visual Science, Apr. 2003, 44:1492-1500. [cited by applicant]
Hahner et al., “Strategies for SNP genotyping by mass spectrometry,” International Congress Series, Jan. 2003, 1239: 11-16. [cited by applicant]
Halushka et al., “Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis”, Nat Genet, 1999, 239-247. [cited by applicant]
Hattersley et al., “What makes a good genetic association study?” The Lancet, Oct. 2005, 366(9493):1315-1323. [cited by applicant]
Hirschhorn et al., “A comprehensive review of genetic association studies,” Genetics in Medicine, 2002, 4(2):45-61. [cited by applicant]
Hofer et al., “Organization of the Human Trichromatic Cone Mosaic,” Journal of Neuroscience, Oct. 19, 2005, 25(42):9669-9679. [cited by applicant]
Jones et al., “The Prevalence and Impact of High Myopia,” Eye & Contact Lens, May 2012, 38(3):188-96. [cited by applicant]
JP Office Action in Japanese Appln. No. 2020-541739, dated Sep. 13, 2021, 19 pages (with translation). [cited by applicant]
Kuchenbecker et al., “Topography of the long-to middle-wavelength sensitive cone ratio in the human retina assessed with a wide-field color multifocal electroretinogram,” Vis Neurosci, May-Jun. 2008, 25(3):301-6. [cited by applicant]
Lam et al. “Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial,” Br J Ophthalmol, Mar. 2019, 104(3):363-368. [cited by applicant]
Lucentini, “Gene association studies typically wrong: reproducible gene-disease associations are few and far between”, The Scientist, 2004, 18(24): p. 20. [cited by applicant]
McClements, Michelle et al. “Variations in Opsin Coding Sequences Cause X-Linked Cone Dysfunction Syndrome, with Myopia and Dichromacy” Investigative Ophthalmology & Visual Science (2013) vol. 54(2), pp. 1361-1369. [cited by applicant]
McMahon et al., “The L:M cone ratio in males of African descent with normal color vision,” Journal of Vision, 2008, 8(2):1-9. [cited by applicant]
Michaelides et al., “X-Linked Cone Dysfunction Syndrome with Myopia and Protanopia” Ophthalmology, Aug. 2005, 112(8): 1448-1454. [cited by applicant]
Michaelides, et al. (2010) “The PROM1 mutation p.R373C causes an autosomal dominant bull's eye maculopathy associated with rod, rod-cone, and macular dystrophy,” IOVS, 51(9): 4771-4780. [cited by applicant]
Mizrahi-Meissonnier et al., “Variable Retinal Phenotypes Caused by Mutations in the X-Linked Photopigment Gene Array,” Investigative Ophthalmology & Visual Science, Aug. 2010, (51):3884-3892. [cited by applicant]
Montana.edu [online] “Optical System Design—S15” retrieved on Jan. 7, 2019, retrieved from <http://www.montana.edu/jshaw/documents/18%20EELE582_S15_OTFMTF.pdf >, 18 pages. [cited by applicant]
Mummidi et al., “Evolution of Human and Non-human Primate CC Chemokine Receptor 5 Gene and mRNA,Potential Roles for Haplotype and mRNA Diversity, Differential Haplotype-Specific Transcriptional Activity, and Altered Tra… [cited by applicant]
Nathans et al., “Molecular Genetics of Human Blue Cone Monochromacy”, Aug. 1989, 45(4920): pp. 831-838. [cited by applicant]
Nathans et al., “Molecular Genetics of Inherited Variation in Human Color Vision”, Apr. 1986, 232(4747): pp. 203-210. [cited by applicant]
NCBI Database GenBank Accession No. NM 020061, Nov. 1, 2009, National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD, USA, 7 pages. [cited by applicant]
Neitz et al. “Variety of genotypes in males diagnosed as dichromatic on a conventional clinical anomaloscope”, Visual Neuroscience, 2004, 21(3):205-216. [cited by applicant]
Neitz et al., “Cone mosaic disruption caused by L/M opsin mutations in bornholm eye disease,” ARVO Annual Meeting Abstract, Apr. 2011, 2 pages. [cited by applicant]
Neitz et al., “Polymorphism in the number of genes encoding long-wavelength-sensitive cone pigments among males with normal color vision”, Vision Research, Sep. 1995, 35(17): 2395-2407. [cited by applicant]
Neitz, “A new mass screening test for color-vision deficiencies in children” Color Research & Application, 2001, 26(1): S239-S249. [cited by applicant]
Oda, et al. (2003) “Analysis of L-cone/M-cone visual pigment gene arrays in females by long-range PCR” Vision Research, vol. 43, pp. 489-495. [cited by applicant]
Office Action in Chinese Appln. No. 201980016486.9, dated Jun. 12, 2024, 15 pages (with English translation). [cited by applicant]
Office Action in Japanese Appln. No. 2023-163696, dated Apr. 22, 2024, 12 pages (with English translation). [cited by applicant]
Okada et al., “Target Spatial Frequency Determines the Response to Conflicting Defocus- and Convergence-Driven Accommodative Stimuli,” 2006, Elsevier, vol. 46, pp. 475-484. [cited by applicant]
PCT International Preliminary Report on Patentability and Written Opinion in International Application No. PCT/US2019/015724, dated Aug. 13, 2020, 7 pages. [cited by applicant]
PCT International Search Report and Written Opinion in International Appln. PCT/US19/15724, dated Jun. 7, 2019, 10 pages. [cited by applicant]
Radhakrishna, et al., “The ‘X-linked’ severe form of myopia locus at Xq28 (MYP1): Narrowing of the critical region and exclusion of twelve known genes localized in the interval.”, ARVO Annual Meeting Abstract, May 2005,… [cited by applicant]
Ruiz-Pomeda et al., “MiSight Assessment Study Spain (MASS). A 2-year randomized clinical trial,” Graefe's Archive for Clinical and Experimental Ophthalmology, Feb. 3, 2018, 256:1011-1021. [cited by applicant]
Sankaridurg et al., “Decrease in rate of myopia progression with a contact lens designed toreduce relative peripheral huperopia: One-year results,” IOVS, Dec. 2011, 52(13):9362-9367. [cited by applicant]
Scholl et al., “Macular dystrophy with protan genotype and phenotype studied with cone type specific ERGs,” Current Eye Research, 2001, 22(3):221-228. [cited by applicant]
Scholl et al., “Progressive cone dystrophy with deutan genotype and phenotype,” Graefe's Arch Clin Exp Ophthalmol, 2006, 244:183-191. [cited by applicant]
Schwartz et al., “X-linked myopia: Bornholm Eye Disease”, Clinical Genetics, 1990, 38(4):281-286. [cited by applicant]
Slrlounge.com [online] “Diffraction, Aperture, and Starburst Effects,” dated Feb. 9, 2011, [retrieved on Jan. 7, 2019] Retrieved from: <https://www.slrlounge.com/diffraction-aperture-and-starburst-effects/>, 11 pages. [cited by applicant]
Tedja et al., “Genome-wide association meta-analysis highlights light-induced signaling as a driver for refractive error”, Nature Genetics, Jun. 2018, 50(6):834-848. [cited by applicant]
TW Office Action in Taiwanese Appln. No. 108103396, dated Dec. 18, 2019, 6 pages (with English translation). [cited by applicant]
TW Office Action in Taiwanese Appln. No. 108103396, dated Sep. 10, 2019, 32 pages (with English translation). [cited by applicant]
TW Office Action in Taiwanese Appln. No. 109123077, dated Feb. 17, 2021, 6 pages (with English translation). [cited by applicant]
Twelker et al., “Children's Ocular Components and Age, Gender, and Ethnicity,” Optometry and Vision Science, Aug. 2009, 86(8):918-935. [cited by applicant]
Ueyama et al., “Unique haplotype in exon 3 of cone opsin mRNA affects splicing of its precursor, leading to congenital color vision defect,” Biochemical and Biophysical Research Communications, 2012, 424(1):152-157. [cited by applicant]
Verrelli et al., “Signatures of Selection and Gene Conversion Associated with Human Color Vision Variation”, The American Journal of Human Genetics, 2004,75(3): 363-375. [cited by applicant]
Vitale et al., “Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004,” Arch Ophthalmol., Dec. 2009, 127(12):1632-1639. [cited by applicant]
Winderickx et al., “Defective colour vision associated with a missense mutation in the human green visual pigment gene”, Nat Genet 1992, 251-256. [cited by applicant]
Winderickx, et al. (1993) “Haplotype diversity in the human red and green opsin genes: evidence for frequent sequence exchange in exon 3,” Human Molecular Genetics, 2(9):1413-1421. [cited by applicant]
Young et al., “X-Linked High Myopia Associated With Cone Dysfunction”, Arch Ophthalmol. 2004, 122(6):897-908. [cited by applicant]
Young, et al., (2001) “Further refinement of the MYP2 locus for autosomal dominant high myopia by linkage disequilibrium analysis”, Ophthalmic Genetics, vol. 22, pp. 69-75. [cited by applicant]
Zhang, “Genetics of Refraction and Myopia”, Progress in Molecular Biology and Translational Science, 2015, 134: 269-279. [cited by applicant]
Office Action in Chinese Appln. No. 201980016486.9, mailed May 1, 2025, 7 pages (with English translation). [cited by applicant]